FDA CONSUMER UPDATE
U.S. Food and Drug Administration
Radiological Health Consumer Update on Wireless Phones
1. Do wireless phones pose a health hazard?
The available scientific evidence does not show that any health problems are associated with using wireless phones. There is no proof, however, that wireless phones are absolutely safe. Wireless phones emit low levels of radiofrequency energy (RF) in the microwave range while being used. They also emit very low levels of RF when in the
2. What is FDA’s role concerning the safety of wireless phones?
Under the law, FDA does not review the safety of
•Support needed research into possible biological effects of RF of the type emitted by wireless phones;
•Design wireless phones in a way that minimizes any RF exposure to the user that is not necessary for device function;
and
• Cooperate in providing users of wireless phones with the best possible information on possible effects of wireless phone use on human health.
FDA belongs to an interagency working group of the federal agencies that have responsibility for different aspects of RF safety to ensure coordinated efforts at the federal level. The following agencies belong to this working group:
•National Institute for Occupational Safety and Health
•Environmental Protection Agency
•Federal Communications Commission
•Occupational Safety and Health Administration
•National Telecommunications and Information Administration
The National Institutes of Health participates in some
CUnited States must comply with FCC safety guidelines that limit RF exposure. FCC H relies on FDA and other health agencies for safety questions about wireless
phones. FCC also regulates the base stations that the wireless phone networks
7 rely upon. While these base stations operate at higher power than do the wireless phones themselves, the RF exposures that people get from these base stations are typically thousands of times lower than those they can get from wireless phones. Base stations are thus not the subject of the safety questions discussed in this document.
3. What kinds of phones are the subject of this update?
The term “wireless phone” refers here to
FDA CONSUMER UPDATE
These types of wireless phones can expose the user to measurable radiofrequency energy (RF) because of the short distance between the phone and the user’s head. These RF exposures are limited by Federal Communications Commission safety guidelines that were developed with the advice of FDA and other federal health and safety agencies. When the phone is located at greater distances from the user, the exposure to RF is drastically lower because a person’s RF exposure decreases rapidly with increasing distance from the source. The
4. What are the results of the research done already?
The research done thus far has produced conflicting results, and many studies have suffered from flaws in their research methods. Animal experiments investigating the effects of radiofrequency energy (RF) exposures characteristic of wireless phones have yielded conflicting results that often cannot be repeated in other laboratories. A few animal studies, however, have suggested that low levels of RF could accelerate the development of cancer in laboratory animals. However, many of the studies that showed increased tumor development used animals that had been genetically engineered or treated with
5.What research is needed to decide whether RF exposure from wireless
phones poses a health risk?
A combination of laboratory studies and epidemiological studies of people actually using wireless phones would provide some of the data that are needed. Lifetime animal exposure studies could be completed in a few years. However, very large numbers of animals would be needed to provide reliable proof of a cancer promoting effect if one exists. Epidemiological studies can provide data that is directly applicable to human populations, but 10 or more years’
6.What is FDA doing to find out more about the possible health effects of wireless phone RF?
FDA is working with the U.S. National Toxicology Program and with groups of investigators around the world to ensure that high priority animal studies are conducted to address important questions about the effects of exposure to radiofrequency energy (RF). FDA has been a leading participant in the World Health Organization International Electromagnetic Fields (EMF) Project since its inception in 1996. An influential result of this work has been the development of a detailed agenda of research needs that has driven the establishment of new research pro- grams around the world.
C H
7
126 | 127 |